AbbVie Shares Drop Amid Missed Sales Expectations for Key Drugs

Text size AbbVie stock is up 15.4% so far this year. Courtesy of AbbVie In a quarterly earnings report out Friday, the drugmaker AbbVie cut its full-year earnings guidance, and a number of its key drugs missed Wall Street estimates. The company’s first-quarter earnings were roughly in line with Wall Street expectations. AbbVie (ticker: ABBV) … Read more

Stocks for the Recession That May — or May Not — Be Coming

Text size Exelon stock offers a little bit of offense to go with its defense. Dreamstime The yield curve briefly inverted this past week — and that’s a recession signal that is either like Paul Revere’s ride or the boy who cried wolf. The good news: Investors do not need to decide which just yet. … Read more